Travel Health Evidence

Practegol

Bwyta dramor gyda chlefyd coeliac neu alergedd bwyd

Mae rhwystr iaith yn troi cyflwr rheoledig yn gamblo. Mae'r ateb yn bennaf logistaidd, ac mae'n werth ei wneud cyn i chi adael.

Diweddarwyd 3 min darllen 40 dyfyniadau Cryfder tystiolaeth 3/5

Ardal aros neuadd ymadael maes awyr gyda rhesi o seddi a golau dydd o fyny
Jwh · CC BY-SA 3.0 lu · Wikimedia Commons

Beth mae rheolau'r UE yn ei rhoi i chi

Mae'n rhaid datgelu'r pedair ar ddeg o alergeddau mawr — gan gynnwys gwenith sy'n cynnwys gluten — ledled yr UE, mewn bwyd pecynnu a mewn gwasanaeth bwyd. Mae'r rheolau'n ddigon cyson fel bod teithiwr coeliac sy'n symud rhwng aelod-wladwriaethau yn wynebu'r un fframwaith arwyddion, sy'n fantais sylweddol ac sydd heb ei chydnabod yn ddigon.

Beth sy'n amrywio yw gorfodi, sut mae gwasanaeth bwyd yn datgelu (llafar, ar fwydlen, mewn ffolder), a chyfarwyddyd diwylliannol gyda'r cyflwr. Mae gan rai gwledydd ymwybyddiaeth gyhoeddus uchel o glefyd coeliac; mae eraill yn ei thrin fel dewis.

Y system ymarferol

  1. Cymrwch gardiau cyfieithu yn yr iaith leol, gan nodi'r cyflwr yn feddygol, gan enwi'r hyn sy'n rhaid ei osgoi, a chynnwys ffrïwyr a phennau a rennir. Mae cardiau'n mynd i'r gegin; ni fydd brawddeg lafar yn gwneud hynny.
  2. Dysgwch ddarllen y rhestr gynhwysion, nid yr iaith. Mae alergennau'n cael eu pwysleisio'n deipograffig ledled yr UE, felly gallwch eu darganfod heb ddarllen y gweddill.
  3. Cymrwch lety gyda rhewgell a theclyn. Mae'n troi taith anodd yn un arferol.
  4. Cymrwch fwyd diogel ar ddiwrnodau teithio. Mae maes awyr, gorsafoedd a theithiau hir yn lleoedd lle mae pobl yn cael eu dal.
  5. Dewch o hyd i gymdeithas leol coeliac neu alergedd. Mae gan fwyafrif y gwledydd Ewropeaidd un, mae sawl un yn cyhoeddi rhestrau lleoliadau.
  6. Cymrwch ddigon o feddyginiaeth — gan gynnwys injecsiynau auto-adrenalin lle bo'n berthnasol — a chymrwch lythyr presgripsiwn.

Yswiriant a dogfennaeth

Gwiriwch fod yswiriant teithio yn cwmpasu eich cyflwr, a chymrwch ddogfennaeth unrhyw feddyginiaeth yn y pecyn gwreiddiol gyda llythyr presgripsiwn. O fewn yr UE, mae'r Cerdyn Iechyd Ewropeaidd yn cwmpasu triniaethau sydd eu hangen a gynhelir gan y wladwriaeth, nad yw'n yr un peth â yswiriant teithio ac ni fydd yn ei ddisodli.

Cwestiynau cyffredin

A yw cardiau cyfieithu'n ddefnyddiol mewn gwirionedd?
Ydyn, yn fwy na siarad. Gellir rhoi cerdyn i'r gegin, sef lle mae'r penderfyniadau'n cael eu gwneud.
Pa wledydd Ewropeaidd sydd hawsaf gyda chlefyd coeliag?
Mae ymwybyddiaeth yn amrywio mwy na rheoleiddio. Cymdeithasau coeliag cenedlaethol yw'r ffynhonnell orau ar hyn o bryd yn hytrach nag unrhyw gyffredinoliad.
A allaf fynd â'm meddyginiaeth ar draws ffiniau?
Yn gyffredinol gellir, mewn pecynnu gwreiddiol gyda llythyr presgripsiwn. Gwiriwch sylweddau a reolir yn benodol.
Beth os byddaf yn cael fy nglwtenu dramor?
Rheolwch symptomau a hydradiad. Nid oes triniaeth ar gyfer amlygiad — gweler ein gwefan coeliag.
Mewnol i awyren cul gyda loceri uwchben a seddi tri yn eang
Aykleinman (talk) · Public domain · Wikimedia Commons

Darllen cysylltiedig

Y dystiolaeth y tu ôl i'r dudalen hon Bar wedi'i stacio sy'n dangos cyfansoddiad y 26 cyhoeddiad a grybwyllir ar y dudalen hon yn ôl math astudiaeth. 11855meta-analysis (11)randomised trial (8)review (5)other (5)
29 cyhoeddiadau, 1987–2026. Mae hynny'n gymysgedd sy'n cynnwys y ddau dreial a synthese, sy'n sefyllfa lle mae honiad am achos yn rhesymol. Ffynhonnell: rhestr dyfynnu'r dudalen hon ei hun, isod.

Cyfeiriadau

Mae pob dyfyniad isod yn cysylltu â'r cofrestr adolygedig cyfoes gwreiddiol ar PubMed neu trwy DOI. Nid yw dim yma yn gymhwysedd ar gyfer cyngor meddygol.

  1. Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
  2. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
  3. Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
  4. Risk of anaphylaxis on commercial flights Turner PJ · Current opinion in allergy and clinical immunology · 2025 · Systematic review DOIPubMed 40643054Full text
  5. How Common Are Allergic Reactions During Commercial Flights? A Systematic Review and Meta-Analysis Turner PJ, Mamula J, Laktabi J, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Meta-analysis DOIPubMed 37507067
  6. Skin care interventions in infants for preventing eczema and food allergy Kelleher MM, Cro S, Cornelius V, et al. · The Cochrane database of systematic reviews · 2021 · Meta-analysis DOIPubMed 33545739Full text
  7. Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children Perez Chacon G, Ramsay J, Brennan-Jones CG, et al. · The Cochrane database of systematic reviews · 2021 · Systematic review DOIPubMed 34693993Full text
  8. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
  9. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement Vultaggio A, Agache I, Akdis CA, et al. · Allergy · 2020 · Clinical guideline DOIPubMed 32500526Full text
  10. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
  11. Frequency, severity and causes of unexpected allergic reactions to food: a systematic literature review Versluis A, Knulst AC, Kruizinga AG, et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015 · Systematic review DOIPubMed 24766413
  12. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community Muraro A, Agache I, Clark A, et al. · Allergy · 2014 · Clinical guideline DOIPubMed 24905609
  13. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
  14. Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies Chinthrajah RS, Kulis M, Jones SM, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 41238005Full text
  15. PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort Denlinger LC, Israel E, Moore WC, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 41707916Full text
  16. Early-life peanut oral immunotherapy associated with long-term ingestion and immunologic changes Dantzer JA, Virkud YV, Cox AL, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 42167657Full text
  17. Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial Morgan WJ, Mauger DT, Bacharier LB, et al. · Lancet (London, England) · 2026 · Randomised controlled trial DOIPubMed 42705251
  18. Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial Palmer DJ, Cuthbert AR, Sullivan TR, et al. · The Journal of allergy and clinical immunology · 2025 · Randomised controlled trial DOIPubMed 39173718
  19. A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy Zoratti E, Wood R, Pomés A, et al. · The Journal of allergy and clinical immunology · 2024 · Randomised controlled trial DOIPubMed 38718950Full text
  20. Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy Wang J, Wood RA, Raymond S, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Randomised controlled trial DOIPubMed 37087097Full text
  21. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial Kliewer KL, Gonsalves N, Dellon ES, et al. · The lancet. Gastroenterology & hepatology · 2023 · Randomised controlled trial DOIPubMed 36863390Full text
  22. Impact of an Intervention on Healthy Offerings and Allergenic Food Management in Restaurants: A Parallel Randomized Controlled Study Tarro L, Mandracchia F, Queral J, et al. · Nutrients · 2023 · Randomised controlled trial DOIPubMed 38068728Full text
  23. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial Jackson DJ, Bacharier LB, Gergen PJ, et al. · Lancet (London, England) · 2022 · Randomised controlled trial DOIPubMed 35964610Full text
  24. Randomized, double-blind, placebo-controlled, food allergy challenge to olestra snacks Burks AW, Christie L, Althage KA, et al. · Regulatory toxicology and pharmacology : RTP · 2001 · Randomised controlled trial DOIPubMed 11603960
  25. Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper Pascal M, Chauhan J, Knol E, et al. · Allergy · 2025 · Review DOIPubMed 40503572Full text
  26. The epithelial barrier theory and its associated diseases Sun N, Ogulur I, Mitamura Y, et al. · Allergy · 2024 · Review DOIPubMed 39370939Full text
  27. Scope and applicability of social-ecological resilience to antimicrobial resistance Wernli D, Søgaard Jørgensen P, Parmley EJ, et al. · The Lancet. Planetary health · 2023 · Review DOIPubMed 37438004
  28. Safe Living Following Solid Organ Transplantation Blair BM · The Surgical clinics of North America · 2019 · Review DOIPubMed 30471739
  29. Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
  30. IgE in the diagnosis and treatment of allergic disease Platts-Mills TAE, Schuyler AJ, Erwin EA, et al. · The Journal of allergy and clinical immunology · 2016 · Review DOIPubMed 27264001Full text
  31. The restaurant syndromes Settipane GA · New England and regional allergy proceedings · 1987 · Review DOIPubMed 3302666
  32. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 The Lancet. Infectious diseases · 2026 · Journal article DOIPubMed 41412141
  33. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021 Rautalin I, Volovici V, Stark BA, et al. · JAMA neurology · 2025 · Journal article DOIPubMed 40406922Full text
  34. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
  35. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
  36. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092928Full text
  37. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text
  38. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study Ozonoff A, Jayavelu ND, Liu S, et al. · Nature communications · 2024 · Journal article DOIPubMed 38172101Full text
  39. Formononetin inhibits IgE by huPlasma/PBMCs and mast cells/basophil activation via JAK/STAT/PI3-Akt pathways Musa I, Wang ZZ, Yang N, et al. · Frontiers in immunology · 2024 · Journal article DOIPubMed 39221239Full text
  40. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 Shin YH, Hwang J, Kwon R, et al. · Allergy · 2023 · Journal article DOIPubMed 37431853Full text

Cafodd y dudalen hon ei thrawsgrifiad yn awtomatig o Saesneg. Mae'r dyfyniadau a'r rhifau heb newid. Darllenwch y gwreiddiol Saesneg os yw unrhyw beth yn darllen yn rhy ddieithr. Darllenwch y gwreiddiol Saesneg